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Abstract
Background: The lack of sensitive biocompatible particle track detectors has so far limited parallel detection of
physical energy deposition and biological response. Fluorescent nuclear track detectors (FNTDs) based on Al2O3:C,Mg
single crystals combined with confocal laser scanning microscopy (CLSM) provide 3D information on ion tracks with a
resolution limited by light diffraction. Here we report the development of next generation cell-fluorescent ion track
hybrid detectors (Cell-Fit-HD).
Methods: The biocompatibility of FNTDs was tested using six different cell lines, i.e. human non-small cell lung
carcinoma (A549), glioblastoma (U87), androgen independent prostate cancer (PC3), epidermoid cancer (A431) and
murine (VmDk) glioma SMA-560. To evaluate cell adherence, viability and conformal coverage of the crystals different
seeding densities and alternative coating with extracellular matrix (fibronectin) was tested. Carbon irradiation was
performed in Bragg peak (initial 270.55 MeV u−1). A series of cell compartment specific fluorescence stains including
nuclear (HOECHST), membrane (Glut-1), cytoplasm (Calcein AM, CM-DiI) were tested on Cell-Fit-HDs and a single
CLSM was employed to co-detect the physical (crystal) as well as the biological (cell layer) information.
Results: The FNTD provides a biocompatible surface. Among the cells tested, A549 cells formed the most uniform,
viable, tightly packed epithelial like monolayer. The ion track information was not compromised in Cell-Fit-HD as
compared to the FNTD alone. Neither cell coating and culturing, nor additional staining procedures affected the
properties of the FNTD surface to detect ion tracks. Standard immunofluorescence and live staining procedures could
be employed to co-register cell biology and ion track information.
Conclusions: The Cell-Fit-Hybrid Detector system is a promising platform for a multitude of studies linking biological
response to energy deposition at high level of optical microscopy resolution.
Background
To better understand the molecular mechanisms govern-
ing the radiobiological effects of particle therapy or space
radiation simultaneous detection of cellular response and
physical energy deposition is desired.Moreover, the grow-
ing field of particle therapy using protons and heavier
ions (e.g. carbon) urgently needs novel means of bio-
logical dosimetry to accurately account for difference in
relative biological effectiveness (RBE) [1], as a function
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of a plethora of particle variables such as location of
ion traversal, ion type, energy and linear energy transfer
(LET).
Earlier approaches to correlate physical radiation
parameters with biological endpoints like cell survival
(e.g. BIOSTACK experiment [2,3] and cell-coated CR39
detectors [4]) were hindered by a limited set of physical
parameters that could be obtained. In addition, inability to
autoclave the detector before cell deposition hindered the
sterile cell cover.
Here we devise a novel strategy to establish a cell-
fluorescent ion track hybrid detector (Cell-Fit-HD) based
on fluorescent nuclear track detectors (FNTDs, Figure 1a).
FNTDs based on Al2O3:C,Mg single crystals provide
almost 100% detection efficiency of ion tracks imaged
by confocal laser scanning microscope (CLSM) [5,6].
© 2013 Niklas et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
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Figure 1 Fluorescent nuclear track detector (FNTD). (a) Two FNTDs (8 × 4 × 0.5 mm3). Courtesy of M.S. Akselrod, Landauer Crystal Growth
Division. (b) Fluorescent image of the 270.55 MeV u−1 carbon-ion tracks propagating perpendicular to the FNTD crystal surface. The brightest spots
(physical energy deposition events) are attributed to carbon ions with a full width half maximum (FWHM) of approximately 500 nm [9]. The smaller,
less intense spots to less densely ionizing particles like protons. The small structures around the carbon ion tracks arise from secondary electrons
(sec e-) [10]. Insert: magnification of a single track spot. The track core is encoded by dark red. Scale bar, 5 μm. (c) FNTD image after carbon
irradiation (initial 270.5 MeV u−1) parallel to the polished crystal surface. Secondary electron structures (small trajectories branching from the ion
track) are visible. Instead of homogeneous energy deposition discrete blobs (bright spots) occur along the particle tracks. This is an illustration of
stochastic nature of energy deposition along the heavy charged particle track. Courtesy of F. Lauer. Scale bar, 5 μm.
3D information on energy deposition of ion tracks was
obtained with diffraction-limited resolution and a mul-
titude of physical parameters derived, such as location,
direction, and possibly particle type and LET [6-9].
To develop the Cell-Fit-HD, the Al2O3:C,Mg crystal was
autoclaved and coated with different human and murine
cell lines to form a cell-crystal hybrid sample. We report
here the successful development of protocols to grow
human and murine cells on FNTDs to create a viable cell
layer. To evaluate potential spectrum of applications for
Cell-Fit-HD, we successfully tested different staining and
fixation protocols for co-detection of different biological
compartments and radiation particles parameters. Here,
we demonstrate the feasibility of sequential read-out of
the physical and biological information using CLSMwith-
out removing the cell layer from the Al2O3:C,Mg single
crystal. The Cell-Fit-HD technology may provide a novel
tool for of spatial correlation between biological readouts
and single ion traversals.
Methods
Al2O3:C,Mg based FNTDs
The FNTDs are made of aluminum oxide single crystals
doped with magnesium and carbon ions (α-Al2O3:C,Mg).
The fluorescent color centers in these crystals are
F2+2 (2Mg)-centers. They are the aggregate defects formed
by two oxygen vacancies and two Mg-ion impurities [6].
Pristine F2+2 (2Mg) color centers can be excited at 435
nm optical absorption band and emit fluorescent light at
520 nm. By exposing the detector to ionizing radiation,
secondary electrons are generated, captured by the defects
and transform them into F+2 (2Mg) color centers. The
radiation-transformed color centers have different optical
properties: they absorb light in a band centered at 620 nm
light, prompting fast 750 nm fluorescence. The intensity
of this radiation-induced 750 nm fluorescence depends on
local energy deposition of ionizing radiation. Accordingly,
FNTDs allow for high spatial resolution particle track
visualization by confocal microscopy [6] (Figure 1b,c) and
subsequent 3D particle track reconstruction [7,11]. The
system is sensitive for ions with LET > 0.5 keV μm−1
[5,8]. FNTD offers a detection efficiency close to 100% for
the entire spectrum of primary particles and fragments at
energies found in ion beam cancer therapy [5]. The cur-
rent limit of maximum accessible track fluence is in the
range of 5 · 107 cm−2 [5], relevant to fluences providing
clinical doses.
Cell cultures and characterization
All cells and Cell-Fit-HD were cultured in humidified
atmosphere under standard culture conditions (37°C, 5%
CO2). Human lung adenocarcinoma epithelial (A549) and
human glioblastoma (U87) cells were cultured in Dul-
becco’s modified Eagle medium (DMEM, Biochrom AG,
Berlin, Germany, Cat. No. FG 0415). Human epider-
moid carcinoma (A431) and human prostate cancer (PC3)
cells were cultured in Roswell Park Memorial Institute
(RPMI) 1640 medium (Biochrom AG, Cat. No. FG 1215).
Murine astrocytoma (SMA-560) cells were cultured in
DMEM/Ham’s F-12 liquid medium (Biochrom AG, Cat.
No. FG 4815). All culture media were supplemented with
10% Fetal Bovine Serum (FBS, Biochrom AG, Cat. No. S
0615) and 1% penicillin- streptomycin.
PC3, A549 and A431 cells were obtained from
Deutsche Sammlung von Mikroorganismen und Zellkul-
turen (DSMZ, Braunschweig, Germany), U87 cells were
obtained fromAmerican Type Culture Collection (ATCC)
and SMA-560 was kindly donated by Dr. Wolfgang Wick,
Clinical Cooperation Unit Neurooncology, German Can-
cer Research Center, Heidelberg, Germany.
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Cell-coating of FNTDs
FNTDs were autoclaved and washed in Dulbecco’s
Phosphate-Buffered Saline (DPBS). For direct coating
each FNTD was placed in a well of a multi-well plate (24
Well Cell Culture Multiwell Plate, CELLSTAR, Greiner
Bio-One) and the polished surface was covered with cells
at different plating densities, from 20 · 103, 100 · 103,
300 · 103 to 400 · 103 ml−1, 0.5 ml per well. The Cell-Fit-
HDs were kept in humidified atmosphere until a conflu-
ent monolayer had developed. The medium was changed
the first time after 24 h and then in 48 h intervals and
the cell layer was tightly monitored using a wide-field
microscope equipped with phase contrast filter (Axiovert
40C, Zeiss). To test the feasibility of FNTD surface coat-
ing with extracellular matrix components, FNTDs were
placed in a multiwell plate filled with fibronectin (Bovine
Fibronectin, without Bovine Serum Albumin, R&D Sys-
tems, Minneapolis, USA) at different concentrations (1,
2.5, 5, 10 or 20 ng l−1, diluted with DPBS) and incu-
bated for 50 min at humidified atmosphere. After incu-
bation FNTDs were gently washed twice with DPBS and
covered with cells. Pre-coated FNTDs were sonicated for
15 min and washed with DPBS to remove any solid left-
overs before autoclaving them for reuse.
Cell labeling and immunofluorescence staining
To test whether the FNTD, as a substrate, interferes with
standard fixation and staining procedures, the cell layer of
the hybrid detector was labeled with a series of dyes.
Cells were labeled with a fluorescent dye often used in
life cell imaging, Cell-tracker CM-DiI Molecular Probe,
Cat. No. C700) at a concentration of 1.5 μg l−1 in DPBS
(1 ml) for 8 min at humidified atmosphere first and
then for additional 15 min at room temperature (RT).
After labeling, cells were gently washed twice with DPBS.
Finally, the Cell-Fit-HD was placed in fresh cell cul-
ture medium. For imaging of CM-DiI Leica DM IL LED
inverted widefield-microscope equipped with a mercury
lamp, CY3 green filter cube and a CCD camera (Leica
DFC420 C) were used.
To test viability, A549 cells were stained with
10−3 mol m−3 calcein acetoxymethly ester (Calcein AM,
Molecular Probes, Cat. No. C1430). Prior to staining
the cell layer was washed with DPBS. After incubation
(RT) for 30 min, cells were gently washed with DPBS.
For Calcein AM imaging the inverted CLSM 710, Con-
focor 3 (Zeiss) was equipped with 488 nm Argon laser
line, EC Plan-Neofluar 40x/1.30 oil objective, main
beam splitter (MBS) 488 nm and PMT detection (detec-
tion window: 493- 617 nm). As Calcein was the single
dye detected, there was no potential spectral overlap
within this window. In case of multiple dyes the win-
dow could be narrowed around the emission peak at
513 nm.
For membrane and nuclear dual staining, glucose
transporter (Glut1) specific antibody and a standard
immunofluorescence (IF) protocol were employed. A549
cells were fixed with 4% paraformaldehyde (PFA) in PBS
for 10 min (RT). Cells were washed with PBS. After fix-
ation, cells were permeabilized with 0.1% Triton X-100
in PBS (10 min, RT), washed with PBS, blocked in PBS
containing 2% bovine serum albumin (BSA) (30 min, RT),
and washed with PBS again. Glut1 specific primary anti-
body (Abcam, Cat. No. ab652) was used in a dilution of
1:200 in 1% BSA in PBS with 1 h incubation at RT. After
the washing step with PBS containing 1% BSA secondary
antibody Alexa Fluor 555 goat anti-mouse IgG conjugate
(Molecular Probes, Cat. No. A-21422) was used in dilu-
tion of 1:1000 in 1% BSA/ PBS by incubating for 1 h at
RT. Cells were washed with PBS containing 1% BSA. For
nuclear counter staining, cells were incubated for 5 min
(at RT) in HOECHST 33342 (Molecular Probes, Cat.
No. H1399)/ PBS solution with a final concentration of
2 μg ml−1 and washed with PBS. The CLSM 710 Con-
focor 3 equipped with an EC Plan-Neofluar 40x/1.30 oil
objective was used for imaging of the Glut1/HOECHST
dual staining. We used the 405 nm diode laser line for
HOECHST 33342 and 561 nm Argon laser line for Alexa
Fluor 555. The MBS 458/561 nm and MBS 405 nm were
used for detection of Alexa Fluor 555 and HOECHST
33342 respectively. The detection window for emitted flu-
orescent light of Alexa Fluor 555 and HOECHST 33342
were 566-697 nm and 410-550 nm respectively.
For nuclear staining after irradiation of the Cell-Fit-HD,
the cells were fixed and stained with HOECHST 33342,
15 min post irradiation. For the fixation and IF proce-
dure the same protocol as for the Glut1/HOECHST dual
staining was used.
For imaging with CLSM 710, Confocor 3, the Cell-
Fit-HD was placed in uncoated glass bottom culture
dishes (MatTek Corp., Ashland, USA, Cat. No. P35G-
1.5-10-C). Zeiss ImmersolTM518 F was used as an im-
mersion medium. Fluoromount-GTM (SouthernBiotech,
Birmingham, USA) was used as a mounting medium for
all IF staining except HOECHST 33342 single stain. For
HOECHST 33342 single stain PBS was used. For live
imaging (Calcein AM, CM-DiI) cell culture medium was
used as mounting medium.
Irradiation setup for cell-coated FNTD
Carbon ion irradiations of Cell-Fit-HD were performed
with the therapy beam of the Heidelberg Ion Beam Ther-
apy Center (HIT) at Heidelberg University Hospital. The
ion beam fluence was adjusted to 1.5·106 cm−2 using con-
trols of the treatment system, resulting in an average of 1.3
hits per nucleus (assuming all nuclei to be of equivalent
size with an area of 10 x 10 μm2). In total, a 12 x 12 cm2
field was irradiated homogeneously using raster scanning
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with a pencil beam of 10.1 mm in diameter (full width
at half maximum) and a distance of 2 mm between two
raster spots. Approximately 60,000 particles were deliv-
ered in each spot. The Bragg peak was extended by using
a 3 mm Ripple filter. The cell layer was placed in the rising
flank of the Bragg peak (initial carbon ion energy of 270.55
MeV u−1, corresponding equivalent range in water rH2O=
13.70 cm). As stopping material 11.7 cm of PMMA with
rH2O= 13.57 cmwas placed in front of a multiwall plate (24
Well Cell Culture Multiwell Plate, CELLSTAR, Greiner
Bio-One) containing the cell-coated FNTDs (see Addi-
tional file 1: Figure S1). The multiwell plate was placed
perpendicular to the incident beam. Irradiation setup in
experimental room at HIT with horizontal beam propaga-
tion requires vertical positioning of samples. The FNTD
crystals are 0.5 mm thick with equivalent range in water
rH2O= 1.65 mm. The back side of the FNTDs without cell
coating were facing the incident beam and were attached
to the bottom (polystyrene with rH2O= 1.2 mm) of the
multiwell plate by small agarose droplets. The air gap
between the culture well and the PMMA was not con-
sidered in the total rH2O. Culture wells were filled with
cell culture medium to keep the cell coating viable dur-
ing irradiation. The total amount of materials in front
of the iso center (vacuum exit window, beam applica-
tion monitoring system, air) corresponds to a rH2O of
2.89 mm.
Microscopy settings for sequential read-out of cell-coated
FNTD
For the sequential read-out of the FNTD component and
the cell layer of the Cell-Fit-HD, we used the CLSM
710, Confocor 3 equipped a 63x/1.45 NA oil objective,
APD/PMT/T-PMT detection.
For the FNTD read-out we used the protocol as
described in [10]. The FNTD crystals were scanned by the
633 nm Helium Neon laser line (100% transmission). A
main dichroic beam splitter (MBS) 488/561/633 nm was
used to separate the emission signal from the excitation
light. A 655 nm long-pass filter was used in fluorescent
emission path and the Avalanche Photo Diode (APD) for
emission detection was used in photon counting mode.
The microscope detector pinhole aperture was set to 1
Airy disk diameter unit (AU). The cell layer was imaged
with 405 nm diode laser line (30 mW, 4.0% transmission)
for HOECHST 33342. For the photomultiplier (PMT)
detection of HOECHST 33342, a MBS 405 nm was used
(detection window 410 nm - 495 nm). For the FNTD and
cell layer acquisition, we limited the line-scanning rep-
etition to 4 and a pixel dwell time to 2.80 μs. In both
cases, the size of the imaging field was 134.784 x 134.784
μm2 with a total number of 1152 x 1152 pixels and a
pixel size of 0.117 x 0.117 μm2 (estimated according to
Rayleigh criterion). This results in a frame-acquisition
time of 14.9 s. The acquired FNTD image stack was
adjusted to cover an axial range of about 120 μm (mea-
sured from the detector surface) with a z-interval (z)
of 3 μm. This allows for accurate single ion track recon-
struction as described in [11]. The acquired cell layer stack
covered a range of about 10 μm (z= 0.3 μm).
Results
FNTD crystals are biocompatible
To develop Cell-Fit Hybrid Detectors, first the adher-
ence, viability and growth of different human (A549,
A541, U87, PC3) and murine (SMA-560) cell lines on
the FNTD surface were tested. We were able to pro-
duce a viable and stable cell layer on the polished crys-
tal surface. Cells were seeded directly or after coating
with fibronectin as an intermediate layer to enhance cell
adhesion on the crystal surface (Table 1). We varied the
plating density and fibronectin concentration to optimize
the coating and to quantify cell proliferation kinetics.
SMA-560 (with fibronectin), PC3 (without fibronectin),
A431 (with/without fibronectin) and A549 (with/without
fibronectin) cells were able to form a uniform coating after
24 h using high seeding density (≥ 300,000 ml−1). In com-
parison, the proliferation rate of U87 cells (300,000 ml−1,
with/without fibronectin) was found to be lower. After
120 h these cells still formed a loosely packed network.
For A549 cell line, a uniform cell coating were also be
achieved after longer incubation time (after 48 h) using
lower plating density (100,000 ml−1).
At low seeding concentration (20,000 ml−1) the pro-
liferation rate of SMA-560 (with fibronectin) and U87
cells (with fibronectin) was decreased as compared to
cells growing on the cell culture treated surface, e.g. on
the bottom of the wellplates in which the Cell-Fit-HDs
were incubated. SMA-560 (with fibronectin) developed
a network of overlapping cells on the FNTD’s surface
after 120 h. Lower concentrations of fibronectin (2.5, 5 ng
ml−1) seemed to be favorable for both cell lines using low
seeding concentrations.
Concerning the morphology, all cells were spread and
flat. They exhibited the same shape as grown on stan-
dard cell culture treated surfaces under controlled con-
ditions (incubator, humid atmosphere). In general, the
epithelial tumor cell lines, A549, A431 and PC3 formed
a tightly packed monolayer in comparison with gliomas
SMA-560 and U87 developing networks of overlapping
cells. Figure 2a,b shows a section of a monolayer of A549
cells without additional fibronectin coating. Those cells
exhibited a cubic morphology.
Cell labeling and immunofluorescence staining of
Cell-Fit-HD
To evaluate the feasibility of co-detection of biologi-
















Table 1 Cell-coating experiments
Cell line Seeding density [1/well] Fibronectin [ng/ml] Cell-coating
> 24 h > 48 h > 120 h
SMA-560 10 000 2.5, 5, 10, 20 Single cells, no network Single cells, no network (*) Network of overlapping cells
150 000 2.5, 5, 10, 20 network of overlapping cells
150 000 - - - -
U87 10 000 2.5, 5, 10, 20 single cells, no network single cells, no network (*) single cells, no network
150 000 2.5, 5, 10, 20 loosely packed network
150 000 - loosely packed network
PC3 200 000 2.5 - - -
200 000 - tightly packed monolayer
A431 200 000 2.5 tightly packed monolayer
200 000 - tightly packed monolayer
A549 50 000 - - tightly packed monolayer
150 000 1, 2.5, 5 tightly packed monolayer
150 000 - tightly packed monolayer
The table shows the results of cell coating on the surface of FNTD crystals using different cell lines with and without a fibronectin intermediate layer. Each well contained 500 μl. Cell culture medium was exchanged every
48 h. (*) Proliferation rate is lower compared to cells grown on the untreated bottom of a culture well.
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Figure 2 A549 cell coating. (a) A549 cells cultured on the FNTD crystal surface starting to form a confluent monolayer. A typical island formation
with branching cells is clearly visible. Scale bar, approximately 200 μm (b)Magnified section of a confluent monolayer. The cells are tightly packed.
It is difficult to contrast cells from the transparent crystal substrate with light microscopy. Scale bar, 10 μm. (c) CM-DiI labeled and proliferating cells
forming a confluent monolayer. Scale bar, approximately 200 μm (d) Section of CM-DiI labeled monolayer reveals clear cytoplasmic coloring.
Cytoplasmic granules (multilamellar bodies) exhibit a strong fluorescent signal. Scale bar, approximately 20 μm. (e) Cell layer is labeled with Calcein
AM to test cell viability. The outer red line indicates the cell membrane. The cell nucleus is defined by the inner red line. A strong perinuclear
fluorescent signal with many bright spots (cytoplasmic organelles) and round nuclei indicate good cell viability. Scale bar, 20 μm. (f)
Immunofluorescent labeling of cell nuclei by HOECHST 33342 stain. A uniform monolayer of proliferating cells is visible. Scale bar, 10 μm. Images
(a), (c), and (d) were obtained by wide field microscopy whereas images (b, e, and f) were obtained in confocal fluorescent mode. Images (a)-(e)
show live cell stainings. In (f) cells are fixed with 4% PFA.
the surface of FNTDs, we applied various cell labeling
and immunofluorescence protocols on Cell-Fit-HDs. We
found that the FNTD crystal surface as a substrate is
compatible with all staining protocols tested. Calcein AM
labeling was used for live cell imaging and for deter-
mining the viability of A549 cells (Figure 2e). The high
levels of fluorescence signal as well as the shape of
the cell nuclei indicated good cell viability. The bright
spots are organelles (multilamellar bodies) in the cyto-
plasm with high esterase activity correlating with active
metabolism.
We used CM-DiI labeling as cell tracker dye to achieve
a better contrast between cells and the crystal substrate
(Figure 2c,d). This labeling is based on thiol-reactive
chloromethyl moiety that allows the dye to covalently bind
to cellular thiols. CM-DiI staining suggested exocytotic
activity of cells as small bodies with fluorescent signal are
present in intercellular space.
To estimate the cell density of tightly packed A549
coating we did immunohistochemical analysis and used
HOECHST as nuclear stain (Figure 2f ). The bulk had a
cell density of approximately 6.3 ·105 cm−2. We combined
HOECHST with Glut-1 staining to visualize cell mem-
branes and to detect cell-cell adhesion (Figure 3). There
is strong accumulation of Glut1 at the membrane thus
forming a sharply bounded network. Together, membrane
labeling with Glut1 or CM DiI demonstrated that A549
cells maintained their tight epithelial cell-cell contact in
Cell-Fit-HD.
Irradiation of Cell-Fit-HD and sequential read-out
Placing the A549 cell-coated FNTD in a well filled with
culture medium allows for an easy handling andmounting
for the irradiation (Additional file 1: Figure S1). The cells
stayed alive during irradiation. The total irradiation time
(adjusting the ion-beam fluence to an average of 1.3 hits
per nucleus) was less than 10 s.
After conventional fixation (using 4% PFA) and stain-
ing procedure for HOECHST (cells remained on FNTD)
the detector and the cell layer were imaged successfully
in two consecutive steps using the same CLSM (Figure 4).
No post-irradiation chemical processing of the FNTD or
removal of the cell layer was necessary.
When imaging the cell layer prior to the FNTD,
an increase in the detector background signal in the
surface region (first few μm) occur. We adjusted the scan
and detection parameters (see Methods) of the FNTD
read-out to achieve relatively fast acquisition (frame-
acquisition time of 14.9 s) without forfeiting much signal-
to-noise ratio (SNR).




Figure 3Membrane and nuclear staining of A549 Cell-Fit-HD. (a) Glucose transporter Glut1 staining visualizes the A549 cell membrane. Glut1 is
mainly accumulated at the membrane. The diffuse cytoplasmic signal may arise from permeabilisation during immunofluorescent staining. (b)
HOECHST staining as nuclear counterstain. (c)Merging of Glut1 and HOECHST images. A549 cells form a tightly packed monolayer with strong
cell-cell adhesion. (d) A section of (a) with different color coding (blue-green-yellow) is shown. The distinct yellow bright spots indicate a discrete
strong accumulation of Glut1 at the membrane. Scale bars, 20 μm. (a)-(d) were obtained by confocal fluorescent microscopy.
Figure 5 shows the spatial correlation between carbon
ion tracks and A549 cell layer gained after the sequen-
tial read-out. Compared to cell nuclei (diameter ≈ 10





Figure 4 Sequential read-out of Cell-Fit-HD. To avoid
photoionization of FNTD crystals the imaging is first performed with
the red laser on FNTD crystal and only after that the scan continues
with blue laser on stained cell layer. The total axial range for the
acquired image stack is about 120 μmwith depth increment (z) of
3 μm for FNTD crystal and z= 0.3 μm for the cell-layer. The axial
range for the image stack of cells is about 10 μm. The difference in
optical sectioning is indicated by the striped arrows.
characteristic signature left in the FNTD crystal after
irradiation - have a diameter of less than 1 μm.
Discussion
To our knowledge, we report here the first successful
development of a hybrid detector technology, Cell–Fit–
HD, allowing simultaneous acquisition and correlation of
radiation track information with cellular and molecular
parameters. It was recently shown that Al2O3:C,Mg single
crystal based fluorescent nuclear track detectors (FNTDs)
allow for visualization and characterization of single parti-
cle tracks by conventional fluorescence microscopy [7,11].
Given that confocal microscopy is a common method for
detection of molecular- and cellular biology parameters,
it was hypothesized that development of hybrid detectors
will provide a hitherto unmatched correlation of phys-
ical with biological parameters at high resolution, only
limited by light diffraction [7]. However, little is known
about the properties of the polished and planar detec-
tor surface with regard to their biocompatibility. Based
on the relatively inert chemical reactivity of Al2O3:C,Mg
crystals and their high thermal resistance (up to 600°C)
[12] we were able to successfully autoclave the crystals,
as a prerequisite for sterile cell coverage. The ability of
the FNTD technology to precisely measure energy depo-
sition along carbon ion tracks was neither affected by
autoclaving nor by prolonged exposure to high humidity
under standard culture growth conditions. Next, we tested
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Figure 5 Correlation between carbon ion tracks and A549 cell
layer. Superposition of cellular response data (maximum intensity
z-projection) with an image of the acquired FNTD image stack. The
red spots are the ion tracks (with FWHM of approximately 500 nm [9]).
The small trajectories branching from the ion tracks are tracks of
secondary electrons in the FNTD crystal. The cell nuclei (depicted in
blue) are labeled with HOECHST. The surface of cell-coated FNTD was
set perpendicular to the incident carbon ion beam (small insert).
Initial carbon ion energy was 270.55 MeV u−1 and fluence - 106 cm−2.
Scale bar, 10 μm.
the adherence, the viability and conformal coverage of
the crystals coated with a panel of human and murine
cells.
We found that these crystals are biocompatible for all
of the cell lines tested enabling the development of Cell-
Fit-HD. The cells were spread and flat thus indicating
good cell attachment. Cell adhesion could also benefit
from the doping of Al2O3 with magnesium ions as sev-
eral molecules involved in cell adhesion such as integrins,
have binding sites for divalent ions [13]. In addition the
use of different extracellular matrix (ECM) component to
enhance cell adhesion, as performed in this study, treat-
ment of the crystal surface with plasma or additional
bombardment of the detector surface withMg2+ ions [14]
may further enhance cell adhesion. The crystal surface
was suitable for most of the cell lines tested in order to
gain a viable and uniform cell coating (Table 1). It was
possible to achieve uniform cell coating (Table 1) either
in short incubation time (after 24 h) using high plat-
ing density (≥ 300,000 ml−1) or longer incubation time
using a lower plating density. For the two brain tumor cell
lines, human U87 and murine SMA-560 at low seeding
concentrations (20,000 ml−1) the fibronectin concentra-
tion could further be optimized to improve cell coating
or another extra cellular matrix component like colla-
gen could be tested. The fibronectin layer has a height
of several nm and does not interfere with the limited
mechanical working distance of a microscope objective at
high magnification.
As compared to standard treated surfaces for cell cul-
tures all tested cell lines maintained their morphology
when plated on the crystal surface. Based on the cell types
the tested cell lines formed either glioma-like cell net-
works (SMA-560 and U87) or tightly packed epithelial
monolayers (PC3, A431, A549). The evaluation using con-
ventional phase contrast microscopy was hindered by the
transparency of Al2O3:C,Mg (Figure 2a). Our data indi-
cated that neither the physical properties of the crystal
component nor the physiological properties of the cell
lines were compromised.
We selected A549 cells for subsequent Cell-Fit-HD stud-
ies due to their superior performance in terms of cell
adhesion, viability, proliferation, metabolism and forma-
tion of a tightly packed epithelial network on the crystal
surface without the need of additional ECM coverage.
Al2O3:C,Mg crystal proved to be compatible with stan-
dard fixing and staining procedures. The fluorescent dyes
did not accumulate at the surface nor seemed to affect the
surface properties, hence causing low background during
image acquisition of the cell layer. Moreover, fixation (4%
PFA) did not distort A549 cell morphology when seeded
on the detector surface (Figure 2). The cells can be read-
out in situ on the crystal surface by conventional confocal
microscopy. When reading out the cell layer prior to the
crystal with blue (405 nm) laser light, it is possible to
photoionize pristine F2+2 (2 Mg) color centers in the sur-
face region by two-photon absorption processes resulting
in increase in background 750 nm fluorescence used for
track imaging. To avoid this increase in background signal,
we imaged the crystal with red (633 nm) laser scanning
prior to the cell layer scanning with the blue laser. The
crystal read-out with the red laser in turn does not bleach
fluorescent dyes in the cell layer nor seems to affect the
cell layer in another manner (e.g., morphology). No post-
irradiation chemical processing of the crystal or removal
of the cell layer is necessary for the sequential read-out,
thus eliminating a significant source of error. The high cell
density (A549) with strong cell-cell adhesion (Figure 3)
and fixation directly after irradiation limits cell migra-
tion and distortion of the actual spatial correlation or hit
statistics.
To examine the capability of Cell-Fit-HD to detect bio-
logical processes governing radiation effects in different
cell compartments with physical energy deposition along
ion tracks, visualization of different key cellular compart-
ments was evaluated. Our data indicate that Cell-Fit-HD is
compatible with standard immunofluorescent techniques.
Therefore Cell-Fit-HD may be used to detect radiation
induced molecular events on cell membrane such as dif-
ferential regulation of cell adhesion molecules/receptors
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and their downstream signaling events as demonstrated
by membrane staining using antibody (Glut1) or life dyes
(CM DiI). Moreover, direct damaging effects of ioniz-
ing irradiation in different cellular compartment such
as mitochondria or nucleus could be tested by specific
staining of these compartments as demonstrated here
for DNA-staining in nucleus (HOECHST) or candidate
alternative dyes such as DAPI or ToPro. Together, appli-
cation of standard fluorescent staining techniques on the
cell layer and the sequential read-out of the Cell-Fit-HD
enable spatial correlation between single ion traversal and
cell biology (Figure 5). Currently, algorithms are devel-
oped to correlate the physical information achieved in
crystal compartment with biological events detected in
the cell layer.
Conclusions
Development of a next generation cell-fluorescent ion
track hybrid detector (Cell-Fit-HD) is reported per-
mitting co-detection and direct correlation of physi-
cal and biological information at high resolution using
standard fluorescence microscopy. Detection of physi-
cal energy deposition along carbon ion-tracks is based
on Al2O3:C,Mg crystals (FNTDs). We showed that these
crystals are chemically inert, could be autoclaved and
provide a biocompatible surface for prolonged culture of
different cell lines. The crystals provided a substrate for
a uniform cell coating. Cells maintained their morphol-
ogy, metabolism, proliferated and remained viable for a
long observation period in Cell-Fit-HD. Moreover, the
quality of the FNTD readout was not compromised by
different standard fixation procedures and labeling of dif-
ferent cell compartments using life fluorescent dyes or
immunofluorescence. This offers the possibility of car-
rying out a multitude of live-imaging and fluorescent
staining experiments directly linking the effect of phys-
ical energy deposition along ion tracks with subsequent
cellular events on membrane, cytoplasm, organelles or
nuclear compartment. The here reported method for
development of Cell-Fit-HD will be instrumental for
introduction of a novel generation of compact detectors
facilitating research in radiobiology laboratories with lim-
ited access to more complex detector technologies and
microbeam delivery systems. Cell-Fit-HD can be irradi-
ated with different radiation qualities, i.e. protons and
heavier ions.
Additional file
Additional file 1: Figure S1. Irradiation setup for Cell-Fit-HD. The
Cell-Fit-HD was irradiated perpendicular to the incident carbon ion beam.
Irradiation setup at Heidelberg Ion-Beam Therapy Center (HIT) requires a
vertical positioning of the sample. Only a single well of a multiwell plate is
shown.The FNTD is attached by agarose droplets to the polystyrene
bottom of the multiwell plate. The well is filled with culture medium to
keep the cells viable during irradiation. It is sealed with Parafilm M
(Pechiney Plastic Packaging). The air gap between PMMA block and the
multiwell plate is neglected as the corresponding energy loss is very small.
The range in water (rH2O) of all elements in the beam path (position and
fluence monitors) between exit window of the beam line and isocenter of
the incident ion beam is 2.89 mm.
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